MREM Press Releases
Plexus Breaks Ground On Sixth Manufacturing Facility, Part Of RM1-Billion Expansion In Malaysia
PENANG, July 26 (Bernama) — Plexus Corp. (NASDAQ: PLXS), a global leader in partnering with companies to create products that build a better world, celebrated a significant milestone today with the groundbreaking ceremony of its sixth facility in Penang, Malaysia. The state-of-the-art facility, named “Plexus Bridgeview”, is located in the Bandar
Shanxi Mature Vinegar Brews New Flavors
TAIYUAN, China, July 26 (Bernama-AsiaNet) — When people think of China’s Shanxi province, the ancient “Mature Vinegar” with over 3,000 years of history comes to mind. This unique vinegar, known for its sour, fragrant, sweet, mellow, and fresh flavors, undergoes five main steps and 82 procedures, including steaming, fermenting, smoking, drenching, and aging.
Malaysia Ranks 1st In Southeast Asia For Country Readiness In Global Clinical Trials
KUALA LUMPUR, July 26 (Bernama) — Malaysia is among the Top 30 in the world and leading in Southeast Asia in terms of country readiness for global clinical trials, according to the IQVIA report on Rethinking Clinical Trial Country Prioritization. The report, which was published earlier this month, had mapped global clinical
One Programme, Two Certificates. Mckl Now An SQA Approved Centre!
KUALA LUMPUR, July 26 (Bernama) — Methodist College Kuala Lumpur (MCKL) is proud to announce its new status as a Scottish Qualifications Authority (SQA) approved centre! This prestigious recognition highlights MCKL’s dedication to providing high-quality education and creates new opportunities for students to earn globally recognised qualifications. Students enrolled in MCKL’s
PETRONAS, Enilive and Euglena Reach Final Investment Decision to Construct a Biorefinery in Malaysia
KUALA LUMPUR, July 26 (Bernama) — Petroliam Nasional Berhad (PETRONAS), Enilive S.p.A (a company directly controlled by Eni S.p.A.), and Euglena Co., Ltd. (Euglena) have reached the final investment decision (FID) to develop a biorefinery which will be located within PETRONAS’ Pengerang Integrated Complex (PIC), Johor, Malaysia. The three companies
PETRONAS Signs Three New Discovered Resource Opportunities Production Sharing Contracts in Peninsular Malaysia
KUALA LUMPUR, July 26 (Bernama) — PETRONAS signed Production Sharing Contracts (PSCs) for three (3) clusters of Discovered Resource Opportunities (DRO) marketed under the Malaysia Bid Round Plus (MBR+) Round I. These clusters are located offshore Peninsular Malaysia. Under the Small Field Asset (SFA) Cluster PSC, three (3) fields which consists
AKWEL: Turnover of €528.8M in the first half of 2024
PARIS, France, July 26 (Bernama-GLOBE NEWSWIRE) — Champfromier, Thursday, July 25, 2024 TURNOVER OF €528.8M IN THE FIRST HALF OF 2024 Turnover down -2.8% at constant scope and exchange rates Net cash position of €115.1M on June 30, 2024 AKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and
Xsolla Expands Support In The Greater China Region
BEIJING, July 26 (Bernama-BUSINESS WIRE) — Xsolla, a global video game commerce company known for its extensive suite of tools and services specifically designed for the game industry, is thrilled to announce the grand opening of the Xsolla Greater China Region office. The opening event will occur on Monday, July 22,
Votiro Highlights Continuous Momentum in the Asia-Pacific
SINGAPORE, July 26 (Bernama-BUSINESS WIRE) —Votiro, innovator in Zero Trust Data Detection and Response and trusted to deliver safe and compliant content to industry leaders across the globe, announces significant growth and advancements in Asia-Pacific (APAC) and Japan. The company also shares its plans to advance product functionality within the
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
NEW YORK, July 25 (Bernama-BUSINESS WIRE) — Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced Eisai Inc. (“Eisai”), the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., as one of the first customers to harness its recently announced AI-driven